Auren Rx Review: $199 Semaglutide, No Lock-In

Almost every telehealth GLP-1 seller offers a discount for committing. Almost none of them shows you what you would pay if you did not. Auren Rx (aurenrx.com) publishes both numbers, side by side, on every single product it sells — a subscription rate and an explicit "monthly, no commitment" rate. For a savings desk that is the most useful pricing structure in this batch of seven providers. It also has one disclosure gap large enough to be a dealbreaker for some readers.

The two-rung ladder

Standard semaglutide is $199 a month with no commitment, or $169 subscribed. Standard tirzepatide is $299 with no commitment, or $259 subscribed. The microdose program runs $149 and $250 month to month, or $129 and $229 subscribed.¹

We file the no-commitment figures — $199 and $299 — because that is what you pay if you keep the right to leave, and because the discount here is a real one rather than a repackaged prepay. There is no three-month rung, no six-month rung and no annual plan anywhere on the site. Nothing is being divided by anything, which removes the single most common source of fake monthly prices; the teaser-rate trap covers what that failure normally looks like.

Six months of semaglutide is $1,194 paying monthly against $1,014 subscribed — $180 for the right to cancel, or $30 a month. Tirzepatide is $1,794 against $1,554, a $240 difference.

⚠ Three ways to record the wrong price here

The weight-loss page loads with **tirzepatide already selected**. Open it, glance at the price, and you have filed $299 as "the Auren Rx price" when semaglutide is $199. That is a shifted-column error waiting to happen, and it is live on the site right now.

The site's own structured data publishes the **subscribe** rung rather than the monthly one. Anything reading the machine-readable markup instead of the rendered table records $169 and $259. Both are real prices; neither is what you pay without subscribing. If you find Auren Rx quoted at $169 somewhere, that is where the number came from.

And the navigation reads "Semaglutide and Tirzepatide from $129/mo". The $129 is the **microdose** semaglutide subscribe rung. The cheapest standard GLP-1 rung is $169 subscribed and $199 monthly — $70 a month more than the heading implies. Nothing is fabricated; the heading is just doing more work than the number can support.

The microdose program is an actual program

Where most sellers mention microdosing as a line item, Auren Rx runs it as a named product with its own page, its own intake and its own four-rung table across both molecules. At $149 month to month for semaglutide it is one of the lower verified GLP-1 rungs we track anywhere.

The caveat is clinical, not commercial, and it does not shrink because a company has built a checkout around it: no randomised trial has tested below-label GLP-1 dosing for any outcome. What the evidence actually supports on GLP-1 microdosing is the piece to read before the price tempts you into it.

The rest of the shelf

NAD+ is the deepest line here and every rung is priced: $209 a month for the 100 mg/mL injection, $169 to $249 across four nasal-spray options, and $155 or $215 for the two cream sizes.¹ Sermorelin is $199 monthly, glutathione $119 injectable and $109 nasal, GHK-Cu cream $109, tretinoin $49, oral minoxidil $49, valacyclovir $39 to $49, estradiol $69 to $99. All of those are the no-commitment figures; subscribing takes $10 to $40 a month off depending on the product.

Two products — valacyclovir and estradiol — are not in the site's own sitemap at all. There is no research-chemical shelf, no retatrutide, no testosterone.

Product pages carry star ratings with no review count and no source attached. We do not repeat those.

⚠ What is not disclosed: the states

Auren Rx never publishes the states it operates in. Its terms refer to "certain states" and to "a state where we operate", and no list appears anywhere on the site. Every other provider in this batch either publishes a list or claims all 50. You will not find out whether your state qualifies until you are inside an intake, which is a bad place to discover it. It is the same shape of gap as the operator that names four pharmacies but no reachable price: a company can do most of its disclosure properly and still leave out the one thing you needed before starting.

The pharmacy is also unnamed — described as "Auren RX or one of our partner pharmacies". You may elect to use a local pharmacy of your own instead, in which case the membership fee excludes the medication cost, which changes the arithmetic above entirely. No individual prescriber is named. Clinical services are attributed to Beluga Health, P.A., a real telehealth professional association; the corporate entity is Hades Capital LLC doing business as Auren RX, with no published address.

Billing and cancellation

The membership fee is charged the day membership commences, and it is non-refundable once paid. Membership begins after a provider communicates a care plan and you elect to proceed — so payment follows clinical review rather than preceding it, which is better than four of the other six programs we looked at this week.

Billing runs approximately every 28 to 30 days. That is slightly short of a calendar month, and it is disclosed, which is the whole difference between this and Vyvron's undisclosed four-week cycle that quietly produces thirteen charges a year. Cancellation is month to month by email or in-account, and membership can be paused with no further charges until you order a refill.

The regulatory screen

The trading name, the legal entity, the medical group and the platform vendor all returned zero company-column matches in the FDA's live warning-letter index in August 2026.² The pass carried a positive control — a real February 2026 letter to an unrelated telehealth seller — which returned correctly, so the zeros mean what they appear to mean.

The verdict for a bargain hunter

On structure this is the cleanest price surface in the batch: a no-commitment rung on everything, a correctly labelled billing cadence, granular NAD+ options and nothing to divide. On price, $199 month to month for semaglutide is mid-field — Trellis at $150 and Pepti's $99 flat rung are both cheaper, with their own caveats — while the $149 microdose rung is genuinely low. On disclosure it has one specific failure, and if you live somewhere with restrictive telehealth rules it is the failure that will cost you time. Weigh it against the field on the semaglutide price ladder and with how to choose a GLP-1 provider without overpaying, then check the rest of our research.